Improvement in myocardial energetics and perfusion with Liraglutide in patients with type 2 diabetes- A randomised, single centre, open label, cross-over drug trial
Event:
ESC Congress 2023
Topic:
Imaging
Session:
Cardiomyopathies in myocardial disease